UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 53

Sortiert nach

Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus

Scientific reports, 2021-05, Vol.11 (1), p.10034-10034, Article 10034

2021

Link zum Volltext

Verfügbarkeit prüfen

Research on shifting process control of automatic transmission

Scientific reports, 2022-07, Vol.12 (1), p.13054-13054, Article 13054

2022

Link zum Volltext

Verfügbarkeit prüfen

Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration

Scientific reports, 2024-01, Vol.14 (1), p.1949-1949, Article 1949

2024

Link zum Volltext

Verfügbarkeit prüfen

Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity

Cancer biology & therapy, 2024-12, Vol.25 (1), p.2321767-2321767

2024

Link zum Volltext

Verfügbarkeit prüfen

A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes

Scientific reports, 2024-04, Vol.14 (1), p.9596-9596

2024

Link zum Volltext

Verfügbarkeit prüfen

Characteristic study and design factor analysis of a novel non-pneumatic tyre with V-shaped spokes

Materials & design, 2024-02, Vol.238, p.112681, Article 112681

2024

Link zum Volltext

Verfügbarkeit prüfen

Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period

Scientific reports, 2023-07, Vol.13 (1), p.10767-10767, Article 10767

2023

Link zum Volltext

Verfügbarkeit prüfen

Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin

PloS one, 2015-05, Vol.10 (5), p.e0127599-e0127599

2015

Link zum Volltext

Verfügbarkeit prüfen

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial

BMC medicine, 2023-08, Vol.21 (1), p.300-300, Article 300

2023

Link zum Volltext

Verfügbarkeit prüfen

Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study

Frontiers in oncology, 2022-07, Vol.12, p.909426-909426

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-19-PS11-19

2021

Link zum Volltext

Verfügbarkeit prüfen

Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature

Medicine (Baltimore), 2017-12, Vol.96 (51), p.e9385-e9385

2017

Link zum Volltext

Verfügbarkeit prüfen

Experimental Study on Braking Performance of an AT Integrated Hydraulic Retarder of HPT Series

Journal of physics. Conference series, 2020-10, Vol.1626 (1), p.12102

2020

Link zum Volltext

Verfügbarkeit prüfen

Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate

Journal of the American Academy of Dermatology, 2022-03, Vol.86 (3), p.688-690

2022

Link zum Volltext

Verfügbarkeit prüfen

4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo

Cellular & molecular immunology, 2008-10, Vol.5 (5), p.379-384

2008

Link zum Volltext

Verfügbarkeit prüfen

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab

Medicine (Baltimore), 2019-09, Vol.98 (36), p.e16937-e16937

2019

Link zum Volltext

Verfügbarkeit prüfen

miR‑217‑5p suppresses epithelial‑mesenchymal transition and the NF‑κB signaling pathway in breast cancer via targeting of metadherin

Oncology letters, 2022-05, Vol.23 (5), Article 162

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of progesterone receptor status in 3030 Chinese estrogen receptor positive early breast cancer patients

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12002-e12002

2016

Link zum Volltext

Verfügbarkeit prüfen

Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-κB/IκBα pathway

Oncology reports, 2017-12, Vol.38 (6), p.3455-3464

2017

Link zum Volltext

Verfügbarkeit prüfen

Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)

Scientific reports, 2019-12, Vol.9 (1), p.18135-8, Article 18135

2019

Link zum Volltext

Verfügbarkeit prüfen

miR-217-5p suppresses epithelial-mesenchymal transition and the NF-[kappa]B signaling pathway in breast cancer via targeting of metadherin

Oncology letters, 2022-05, Vol.23 (5), p.1

2022

Link zum Volltext

Verfügbarkeit prüfen

A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Oncology research and treatment, 2019-01, Vol.42 (5), p.269-274

2019

Link zum Volltext

Verfügbarkeit prüfen

Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-[KAPPA]B/I[KAPPA]B[alpha] pathway

Oncology reports, 2017-12, Vol.38 (6), p.3455

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Next-Generation Sequencing (NGS) for Primary Endocrine Resistance on Breast Cancer Patients

Breast (Edinburgh), 2017-11, Vol.36, p.S62

2017

Link zum Volltext

Verfügbarkeit prüfen

PR110 - Impact of Next-Generation Sequencing (NGS) for Primary Endocrine Resistance on Breast Cancer Patients

Breast (Edinburgh), 2017-11, Vol.36, p.S62-S62

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(50)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus

Research on shifting process control of automatic transmission

Bioinformatic analysis reveals an association between Metadherin with breast cancer prognosis and tumor immune infiltration

Role of glutaminyl-peptide cyclotransferase in breast cancer doxorubicin sensitivity

A new prediction nomogram of non-sentinel lymph node metastasis in cT1-2 breast cancer patients with positive sentinel lymph nodes

Characteristic study and design factor analysis of a novel non-pneumatic tyre with V-shaped spokes

Exploring risk factors for totally implantable venous access devices (TIVADs)-related thrombotic occlusion in the off-treatment period

Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin

Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial

Pegylated Liposomal Doxorubicin, Docetaxel, and Trastuzumab as Neoadjuvant Treatment for HER2-Positive Breast Cancer Patients: A Phase II and Biomarker Study

Abstract PS11-19: Metformin improves the survival in Chinese early invasive breast cancer patients with type 2 diabetes mellitus

Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature

Experimental Study on Braking Performance of an AT Integrated Hydraulic Retarder of HPT Series

Pegylated liposomal doxorubicin-induced hand-foot syndrome predicted by serum metabolomic profiling and prevented by calcium dobesilate

4-1BB (CD137) ligand enhanced anti-tumor immune response against mouse forestomach carcinoma in vivo

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab

miR‑217‑5p suppresses epithelial‑mesenchymal transition and the NF‑κB signaling pathway in breast cancer via targeting of metadherin

Prognostic impact of progesterone receptor status in 3030 Chinese estrogen receptor positive early breast cancer patients

Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-κB/IκBα pathway

Pegylated liposomal doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant chemotherapy in locally advanced breast cancer (registration number: ChiCTR1900023052)

miR-217-5p suppresses epithelial-mesenchymal transition and the NF-[kappa]B signaling pathway in breast cancer via targeting of metadherin

A Dose-Escalating Pilot Study (NCT03017404) of Pegylated Liposomal Doxorubicin and Cyclophosphamide, Followed by Docetaxel Administration as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer

Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-[KAPPA]B/I[KAPPA]B[alpha] pathway

Impact of Next-Generation Sequencing (NGS) for Primary Endocrine Resistance on Breast Cancer Patients

PR110 - Impact of Next-Generation Sequencing (NGS) for Primary Endocrine Resistance on Breast Cancer Patients

Suchergebnisse filtern